Position history for Capital Research Global Investors's holdings in VERTEX PHARMACEUTICALS INC
Capital Research Global Investors holds 17.3M shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $7.9B as of 2025-Q4. The position was increased (++4.6% shares). VRTX represents 1.4% of Capital Research Global Investors's portfolio.
Current Value
$7.9B
Current Shares
17.3M
Total Value Change
+$3.8B
Total Shares Change
+8.8M
Other major holders of VRTX: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 17.3M |
+4.6% |
| $7.9B |
| 1.4% |
| $453.74 |
53 |
| 2025-Q3 | Increased | 16.6M | +2.8% | $6.5B | 1.2% | $395.31 | 52 |
| 2025-Q2 | Increased | 16.1M | +10.8% | $7.2B | 1.4% | $441.30 | 56 |
| 2025-Q1 | Increased | 14.5M | +39.4% | $7B | 1.5% | $492.69 | 66 |
| 2024-Q4 | Increased | 10.4M | +15.8% | $4.2B | 0.9% | $399.35 | 52 |
| 2024-Q3 | Increased | 9M | +5.4% | $4.2B | 0.9% | $462.88 | 47 |
| 2024-Q2 | Increased | 8.5M | +48.7% | $4B | 0.9% | $468.72 | 62 |